Page last updated: 2024-09-03

3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine and Stroke

3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine has been researched along with Stroke in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itoh, S; Kawahara, S; Kubo, M; Matsuzaki, M; Tanaka, M; Umeji, K; Umemoto, S1

Other Studies

1 other study(ies) available for 3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine and Stroke

ArticleYear
Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Heart Rate; Hypertension; Imidazoles; Male; Myocardium; Oxidative Stress; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Stroke; Superoxide Dismutase

2005